Ruixin Medical has released a fully automated AI vascular interventional surgical robot, and the "fully automated" intelligent era of precise intervention is approaching.
On August 16th, Reheart Medical held a grand press conference for its fully automated AI vascular interventional surgical robot and launched a forum for Shenzhen's medical research special project in Shenzhen.
At the beginning of the conference, Zheng Lingxiao, the founder and CEO of Reheart Medical, delivered a speech saying that since its establishment in 2017, Reheart Medical has always adhered to its mission - to ensure that every blood vessel receives earlier diagnosis and more precise treatment. By continuously applying technologies such as AI and computational simulation, the company has built a closed - loop diagnosis and treatment system around cardiovascular and cerebrovascular diseases, making Reheart a leading enterprise in cardiovascular functional diagnosis. It was precisely because of this original intention that the company decided to develop a fully automated AI vascular interventional surgical robot.
In 2025, Reheart Medical completed the production of the prototype and phantom experiments of its fully automated AI vascular interventional surgical robot. The company hopes to cooperate deeply with clinical experts to promote subsequent animal experiments, product refinement, clinical registration and other work, and develop products that truly meet clinical needs. It is expected that the fully automated AI vascular interventional surgical robot will be able to complete AI - automated animal surgeries in the second half of this year. Zheng Lingxiao believes that in the future, simple and repetitive clinical surgical procedures can be autonomously completed by AI surgical robots under the supervision of doctors; for challenging surgeries, AI surgical robots can provide stronger assistance to experts.
Professor Yu Bo, the dean of the Cardiovascular Hospital of the Second Affiliated Hospital of Harbin Medical University and the incoming chairman of the Cardiovascular Branch of the Chinese Medical Association, delivered a speech as a representative of authoritative clinical experts. He said that cardiovascular diagnosis and treatment mainly face three pain points: First, doctors bear a heavy physical burden when wearing lead aprons during surgeries. Second, there are differences in manual operations, and it is difficult for young doctors to reach the same - quality and precise training level. Third, there is a resource gap, with uneven distribution of medical resources across the country, and patients often have to travel across provinces for medical treatment.
He proposed: "Through in - depth integration with AI, Reheart Medical has achieved a closed - loop from diagnosis, planning to execution, which greatly saves manpower. More importantly, it is more precise, making complex surgeries no longer rely on experience and enabling grass - roots doctors to perform high - difficulty surgeries with high quality, truly realizing the sinking of high - quality resources. This is also what the country needs, and more patients can enjoy the benefits of intelligent medical care at their doorsteps." Finally, Professor Yu Bo called on colleagues to jointly fulfill the promise between clinical practice and the industry to benefit more cardiovascular patients. "I believe that when the robot holds the guide wire, it extends not only the doctor's hands but also the length of life."
Ma Jun, the co - founder and CTO of Reheart Medical, delivered a report titled "Product Release Report of the Fully Automated AI Vascular Interventional Surgical Robot" on - site. He mentioned that Reheart's fully automated AI vascular interventional surgical robot realizes the tripartite collaboration of "doctor - intelligent system - execution terminal": Doctors issue clinical tasks through natural language interaction (such as voice commands); the intelligent system uses advanced algorithms to convert the instructions into executable operation targets; and then the execution terminal completes the automated surgical operation. The short - term goal of Reheart Medical's fully automated AI vascular interventional surgical robot is to solve doctors' pain points: reduce radiation exposure and the burden of lead aprons, reduce repetitive labor, shorten the training cycle, standardize surgical quality and support telemedicine. Its long - term vision is to use big data and robot technology to make the precision of automated surgeries exceed the human level.
It is worth mentioning that in July, the National Medical Products Administration issued the "Measures for Optimizing the Whole - Life - Cycle Supervision to Support the Innovation and Development of High - End Medical Devices". Reheart Medical's press conference was held against this background. This not only marks the official start of the "fully automated" intelligent era for vascular interventional diagnosis and treatment, but also becomes the first batch of industrialization achievements in the key field of "medical robots + artificial intelligence medical devices" targeted by the new national policy, setting a benchmark for shaping the new quality productivity of medical devices.
Finally, a round - table dialogue session was also held on - site. Hosted by Ma Jun, the co - founder and CTO of Reheart Medical, Professor Yu Bo, Professor Xiu Jiancheng, Director Wang Lei, Dr. Zhou Shoujun, and Zheng Lingxiao, the founder and CEO of Reheart Medical, conducted in - depth discussions on the theme of "The Present and Future of the Fully Automated AI Vascular Interventional Surgical Robot". They shared their insights on hot topics such as technological innovation, clinical application, ethical norms, and future development trends, providing valuable ideas for the development of the industry.
The experts unanimously agreed that the birth and application of any new technology have a development process. AI + fully automated vascular interventional robots are definitely the major trend in the future. It depends on who can have firm confidence and overcome difficulties to be the first to take the plunge.